• 2006

Company Description

ImmuneWorks develops immune tolerance treatments for patients with serious autoimmune diseases in the lung.

ImmuneWorks was founded in 2006 to develop safe and effective immune tolerance treatments for patients with serious autoimmune diseases of the lung. The scientific foundation of the company is ImmuneWorks' groundbreaking discovery that antigen-specific autoimmunity is responsible for the disease in over one-half of idiopathic pulmonary fibrosis (IPF) patients.